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Introduction {#sec1}
============

Emerging data indicate a role for calcium ion channels in bacterial infections ([@bib6], [@bib13]). Bacterial endotoxin can activate transient receptor potential (TRP) channels including TRPV4 in airway epithelial cells, which triggers proinflammatory responses ([@bib1]). The host endeavors to eliminate a pathogen, whereas the pathogen strives to control or escape host defenses. Macrophages are in principle equipped to eliminate bacterial pathogens, but are exploited by virulent *Mycobacterium tuberculosis* as their primary resident host cells by circumventing the macrophage\'s host defense armamentarium. *M. tuberculosis*, the causative agent of human tuberculosis (TB), successfully escapes host defense to establish infection by modulating intracellular trafficking and intracellular calcium signaling as well as through induction of necrotic cell death. However, exposure of macrophages to extracellular ATP and interferon-gamma (IFN-γ) promotes phagosome acidification, generation of reactive nitrogen species (RNS), and apoptosis over necrotic cell death, and hence intracellular killing of *M. tuberculosis*. Mutants lacking the region of differentiation-1 (RD1) encompassing the *esx1*-encoded type 7 secretion system, beside others, are attenuated by failing both, inhibition of phagosome maturation and induction of necrotic cell death. The Esx1-associated small secreted proteins, early secretory antigen target-6 (ESAT-6) and culture filtrate protein 10 (CFP10), are involved in inhibition of phagosome acidification ([@bib5]).

Among the protein family of calcium ion channels, TRP ion channels are involved in immune responses within the lung microenvironment ([@bib27]). TRPA1 is expressed in foamy macrophages and regulates cholesterol metabolism and anti-inflammatory response. TRPM8 and TRPV1 are expressed in lung epithelial cells and are crucial for the synthesis of proinflammatory cytokines, e.g., interleukin (IL)-6, IL-8, tumor necrosis factor (TNF)-α, IL-1α, and IL-1β ([@bib21]; [@bib20]). TRPV4 is highly expressed in alveolar epithelial cells, endothelial cells, neutrophils, and macrophages and important for pro-inflammatory responses, goblet cell recruitment, and airway wall thickening during inflammatory lung diseases ([@bib10], [@bib17], [@bib24]; [@bib8]). Consequently, pharmacological inhibitors of TRPV4 have been considered as therapeutics of acute lung injury ([@bib2]). Inhibition of TRPV4 is associated with impaired *in vitro* neutrophil responses including chemotaxis ([@bib30]). *M. tuberculosis* is known to inhibit calcium signaling in macrophages to reduce phago-lysosome fusion and secure intracellular survival ([@bib15]). These studies strongly suggest that calcium regulation by TRPV4 may be crucially involved in inflammatory lung diseases. To date, there is no report on the role of TRPV4 in *M. tuberculosis* infection. We found that wild-type (WT) *M. tuberculosis,* but not an attenuated ΔRD1 mutant, can down-regulate *Trpv4* expression, thereby inhibiting intracellular calcium mobilization. IFN-γ-activated *Trpv4*^*−/−*^ macrophages failed to restrict *M. tuberculosis* growth due to limited phagosome maturation and nitrite (NO~2~^-^) production. *Trpv4*^*−/−*^ mice showed higher *M. tuberculosis* lung burden associated with lower proinflammatory responses at early time points of infection. However, in the chronic phase of infection, *Trpv4*-deficient mice were superior to WT mice in controlling mycobacterial growth. Our data indicate that *M. tuberculosis* alters TRPV4 expression to facilitate the infection progress. At the late phase of infection, though, TRPV4 facilitates mycobacterial growth indicating TRPV4 as a host-directed therapeutic target for subsidiary treatment of antibiotic therapy of TB.

Results {#sec2}
=======

Trpv4 Expression in Macrophages Is Altered by *M. tuberculosis* {#sec2.1}
---------------------------------------------------------------

To understand Trpv4 regulation during *M. tuberculosis* infection, we analyzed TRPV4 in *M. tuberculosis*-H37Rv-infected murine bone marrow-derived macrophages (BMDM) at protein level. Confocal microscopy revealed association of TRPV4 with the macrophage plasma membrane at 2 h ([Figure 1](#fig1){ref-type="fig"}A, upper panel) but dispersed localization at 24 h post-infection (p.i.) ([Figure 1](#fig1){ref-type="fig"}A, lower panel). Quantification of TRPV4 protein expression in infected BMDM lysates by western blot showed *M. tuberculosis*-H37Rv induced TRPV4 down-regulation at both 24 and 48 h p.i. ([Figure 1](#fig1){ref-type="fig"}B). In contrast, infection with *M. tuberculosis* ΔRD1 transiently down-regulated TRPV4 expression at 24 h but not 48 h p.i. Analysis of *Trpv4* mRNA expression by qRT-PCR in human monocyte-derived macrophages revealed a multiplicity of infection (MOI)-dependent increase in transcript numbers between MOI 1 and 3, which became, however, reduced again at MOI 10 ([Figure 1](#fig1){ref-type="fig"}C). These results demonstrate that infection of macrophages with virulent *M. tuberculosis*-H37Rv redistributes TRPV4 and regulates its expression in an MOI-dependent manner and that loss of TRPV4 is probably not due to reduced, but rather partially compensated, by higher transcription rates.Figure 1Trpv4 Expression and Mycobacterial Survival in Infected Macrophages(A) Bone marrow-derived macrophages (BMDM) isolated from C57BL6/J WT mice were infected with *M. tuberculosis*-GFP (Mtb-GFP) at MOI 5, and the cells were fixed with 4% PFA 2 and 24 h p.i. TRPV4 was detected by immuno-cytochemistry using Cy3-conjugated TRPV4 antibody. Images were acquired using Leica TSC SP5 confocal microscope (scale bar = 5 μm). Mean fluorescence intensity (MFI) of TRPV4 staining was quantified by using Fiji ImageJ software. Statistical analysis was performed with two-way ANOVA. Mean ± SEM (n = 3), ∗p \< 0.05.(B) BMDM from C57BL6/J WT mice were infected with *M. tuberculosis*-H37Rv and *M. tuberculosis* ΔRD1 (MOI 5). Western blot analysis was performed to determine the TRPV4 expression using TRPV4-specific antibody at 2, 24 and 48 h p.i. Densitometry analysis of protein bands was performed using Fiji Image J software.(C) Human monocyte-derived macrophages were infected with *M. tuberculosis*-H37Rv for 24 h at different MOI as indicated, and the mRNA level of *TRPV4* was studied with respect to the reference gene HPRT (hypoxanthine-guanine phosphoribosyltransferase).(D--F) BMDM (D), alveolar macrophages (E), and peritoneal macrophages (F) were isolated from WT and *Trpv4*^*−/−*^ mice; pre-treated with IFN-γ (500 units/mL) overnight; and then infected with *M. tuberculosis* (MOI 1) for 2 h. Cells were lysed with 0.5% Triton X-100 at different time points, and the intracellular *M. tuberculosis* counts were assessed by CFU assay.(G) WT and *Trpv4*^*−/−*^ mice BMDM were infected with *M. tuberculosis* or *M. tuberculosis* ΔRD1, and the intracellular bacterial burden was assessed by CFU assay after cell lysis with 0.5% Triton X-100 at indicated time points. Western blot and confocal images are representative of three independent experiments. In case of CFU assay, "n" corresponds to number of independent experiments. Statistical analysis was performed with two-way ANOVA Bonferroni post-tests. For mRNA expression of TRPV4, statistical analysis was performed with one-way ANOVA. Mean ± SD, ∗p \< 0.05,∗∗p \< 0.01, ∗∗∗p \< 0.001.

*M. tuberculosis* Survives in Activated Macrophages in the Absence of *Trpv4* {#sec2.2}
-----------------------------------------------------------------------------

To assess the role of *Trpv4* in intracellular survival and growth of *M. tuberculosis*, we compared mycobacterial burden in WT and *Trpv4*^*−/−*^ BMDM, alveolar, as well as peritoneal, macrophages, which were either left at the resting state or were stimulated with IFN-γ ([Figures 1](#fig1){ref-type="fig"}D--1F). Compared with WT cells, we observed a slightly better growth of *M. tuberculosis*-H37Rv in resting *Trpv4*-deficient BMDM and alveolar, but not peritoneal, macrophages. However, IFN-γ-activated *Trpv4*^*−/−*^ macrophages of all three types were significantly less capable to restrict the growth of *M. tuberculosis* counts at 48 and 72 h p.i. when compared with WT cells ([Figures 1](#fig1){ref-type="fig"}D--1F). Notably, resting WT but not *Trpv4*^*−/−*^ BMDM were able to control intracellular growth of the *M. tuberculosis* ΔRD1 mutant 48 and 72 h p.i. ([Figure 1](#fig1){ref-type="fig"}G). Similarly, *Mycobacterium smegmatis,* otherwise controlled by WT BMDM were able to grow in *Trpv4*^*−/−*^ cells ([Figure S1](#mmc1){ref-type="supplementary-material"}A). These data were further corroborated by experiments wherein we pretreated the RAW264.7 macrophage cell line with the pharmacological TRPV4 inhibitor RN1734 (10 μM) followed by *M. tuberculosis* infection. Higher *M. tuberculosis* counts were found in RN1734-treated RAW cells when compared with mock-treated controls at 48 h p.i. ([Figure S1](#mmc1){ref-type="supplementary-material"}B). To control for differential phagocytosis rates between resting and IFN-γ-activated WT and *Trpv4*^*−/−*^ macrophages, which may influence subsequent growth, we counted *M. tuberculosis* numbers at 2 h p.i., which, however, were comparable between resting and activated WT and *Trpv4*^*−/−*^ BMDMs ([Figure S1](#mmc1){ref-type="supplementary-material"}C). Taken together, these findings pinpoint TRPV4 as an important host factor for the control of intracellular *M. tuberculosis* by macrophages, in particular when the anti-microbial potential of these cells is potentiated by IFN-γ activation.

*Trpv4* Is Involved in Intracellular Trafficking of *M. tuberculosis* {#sec2.3}
---------------------------------------------------------------------

Virulent mycobacteria are able to survive in resting macrophages by interfering with phagosome maturation by several mechanisms, including attenuation of intracellular calcium ([@bib6] ;[@bib25]), whereas IFN-γ-activated macrophages control mycobacteria, in part by promoting phagosome maturation ([@bib18]). We studied intracellular trafficking of mycobacteria in WT versus *Trpv4*^*−/−*^ macrophages between 5 min and 24 to 48 h p.i. *M. tuberculosis*-GFP co-localized with the early endosomal GTPase, Rab5, in both, IFN-γ-activated WT and *Trpv4*^*−/−*^ macrophages 5 min p.i. At 24 h p.i., mycobacteria in *Trpv4*^*−/−*^ macrophages were still mostly co-localizing with Rab5, indicating retention in early phagosomes in the absence of *Trpv4*, whereas mycobacteria-containing phagosomes in WT macrophages were Rab5 negative ([Figures 2](#fig2){ref-type="fig"}A, 2B, and [S2](#mmc1){ref-type="supplementary-material"}A). In line with this view, *M. tuberculosis*-H37Rv were found in LysoTracker-positive compartments in IFN-γ-activated WT macrophages 48 h p.i. but only to a small extent in *Trpv4*^*−/−*^ BMDM ([Figures 2](#fig2){ref-type="fig"}C and [S2](#mmc1){ref-type="supplementary-material"}B). These results indicate that in the absence of *Trpv4*, IFN-γ-activated macrophages failed to effectively deliver *M. tuberculosis* into acidic phago-lysosomal compartments.Figure 2Localization of *M. tuberculosis* and Intracellular pH Measurement in BMDM Isolated from WT and *Trpv4*^*−/−*^ Mice(A) WT and *Trpv4*^*−/−*^ BMDM were pre-treated with IFN-γ (500 units/mL) overnight. Cells were infected with *M. tuberculosis*-GFP (MOI 5), fixed with 4% PFA at indicated time points, and co-localization of *M. tuberculosis* with Rab5 (arrow marked) was studied using Rab5-specific antibody under Leica TSC SP5 confocal microscope. Images were processed with IMARIS software (Scale bar = 5 μm).(B) At least 100 cells were analyzed to quantify the *M. tuberculosis* and Rab5 co-localization.(C) IFN-γ-stimulated or unstimulated WT and *Trpv4*^*−/−*^ mice BMDM were infected with *M. tuberculosis*-GFP (MOI 5). LysoTrackerRed (100nM) was added to the cells 48 h p.i., incubated for 1 h in dark at 37°C and 5% CO~2~, and fixed with 4% PFA. Colocalization of *M. tuberculosis*-GFP and lysosome was studied using Leica TCS SP5 confocal microscope, and images were processed with IMARIS software (Scale bar = 10 μm).(D) WT and *Trpv4*^*−/−*^ BMDM were incubated with PFA-fixed FITC-labeled *Escherichia coli,* and live-cell imaging was performed by confocal microscopy with 488- and 458-nm filter to track *E. coli* containing phagosome. Phagosomal pH was measured according to pH sensitivity of FITC at ratio 488/458 nm. Experiments were performed under live-cell imaging system with TSC SP5 confocal microscope. "n" corresponds to number of FITC-*E. coli*-containing phagosomes. Statistical analysis was performed with two-way ANOVA Bonferroni post-tests. Experiments were performed in triplicates. Mean ± SD, ∗p \< 0.05, ∗∗\<p \< 0.01, ∗∗∗p \< 0.001.

The influence of TRPV4 on phagosome maturation was further analyzed by determining the phagosomal pH in WT and *Trpv4*^*−/−*^ macrophages upon uptake of non-viable model particles, i.e., fluorescein isothiocyanate (FITC)-labeled paraformaldehyde (PFA)-fixed (PF) *E. coli*. We employed the pH-sensitive property of FITC, which is quenched at acidic pH when excited at 490 nm, but not at 440 nm ([@bib19]). In TRPV4-deficient macrophages, acidification of PF *E. coli* phagosomes was significantly delayed when compared with WT cells ([Figure 2](#fig2){ref-type="fig"}D). These results demonstrate that *Trpv4* plays a crucial role in phagosome acidification and maturation, which are important prerequisites to control intracellular pathogens.

*Trpv4* Influences Generation of Reactive Nitrogen Species and Cell Death upon *M. tuberculosis* Infection {#sec2.4}
----------------------------------------------------------------------------------------------------------

RNS production and apoptotic cell death represent anti-mycobacterial effector mechanisms of IFN-γ-activated macrophages controlling *M. tuberculosis,* at least in mice. It has been shown before that activation of TRPV4 induces RNS production in macrophages ([@bib9]). Therefore, we measured NO~2~^-^ production of IFN-γ-activated WT and *Trpv4*^*−/−*^ BMDM in response to either WT or ΔRD1 *M. tuberculosis*-H37Rv (MOI 5) 24 h p.i. When compared with WT macrophages, we found significantly less nitrite in *Trpv4*^*−/−*^ ones upon infection with either WT or ΔRD1 *M. tuberculosis* ([Figure 3](#fig3){ref-type="fig"}A), which correlated with enhanced intracellular survival of *M. tuberculosis* in *Trpv4*^*−/−*^ macrophages ([Figure 1](#fig1){ref-type="fig"}G).Figure 3Determination of Nitrite Production and Cell Death in Mycobacteria-Infected WT and *Trpv4*^*−/−*^ Mice BMDM(A) WT and *Trpv4*^*−/−*^ BMDM were incubated with or without IFN-γ overnight. Then cells were infected with *M. tuberculosis* or *M. tuberculosis* ΔRD1, and nitrite (NO~2~^-^) production was measured by Griess reagent after 24 h of infection using Biotek multiplate reader.(B) BMDM were infected with *M. tuberculosis* or *M. tuberculosis* ΔRD1 (MOI 5), and cell death was studied by Sytox green (5 μM) assay with a fluorescence Ex/Em of 504/523 nm.(C) WT and *Trpv4*^*−/−*^ BMDM were incubated with or without IFN-γ overnight and infected with *M. tuberculosis*-DsRed. After 3 h of infection, extracellular bacteria were removed by washing, and 10 μM CellEvent caspase3/7 detection reagent in DMEM media was added. Live-cell imaging for 72 h was performed using the biostation imaging system. *M. tuberculosis*-DsRed (red), and caspase3/7 activity (green) was acquired in Cy3 and FITC channel, respectively. Arrows indicates *M. tuberculosis* (red) in the extracellular environment after cell death (Scale bar of magnified image = 10 μm). Each experiment was performed in triplicate. Statistical analysis was performed with two-way ANOVA Bonferroni post-tests. Mean ± SD, ∗p \< 0.05,∗∗\<p \< 0.01, ∗∗∗p \< 0.001.

Intracellular growth of *M. tuberculosis* drives host cell death through oxidative stress-mediated genomic instability ([@bib16]). Therefore, we employed Sytox green to assess necrotic cell death in WT versus *Trpv4*^*−/−*^ BMDM upon infection with WT or ΔRD1 *M. tuberculosis*. We observed significantly higher amounts of DNA released from the cells indicating necrotic cell death in both WT and ΔRD1 *M. tuberculosis*-infected *Trpv4*^*−/−*^macrophages when compared with WT cells. Of note, even the ΔRD1 *M. tuberculosis* mutant, which usually causes apoptotic rather than necrotic macrophage cell death, led to higher necrosis rates in *Trpv4*^*−/−*^ than in WT macrophages ([Figure 3](#fig3){ref-type="fig"}B). To monitor cell death kinetics, we performed live-cell imaging of IFN-γ-activated *M. tuberculosis*-H37Rv-infected BMDM incubated with the fluorogenic caspase3/7 substrate as indicator for apoptosis between 3 and 72 h p.i. ([Figure 3](#fig3){ref-type="fig"}C, and [Video S1](#mmc1){ref-type="supplementary-material"}). *Trpv4*^*−/−*^macrophages succumbed much earlier, i.e., between 24 and 48 h p.i., to *M. tuberculosis* infection likely due to higher intracellular mycobacterial burden. Removal of dead cell aggregates by bystander macrophages eventually resulted in higher rates of cell death in *Trpv4*^*−/−*^ cell cultures when compared with WT ones. Notably, we also observed non-apoptotic cell death independent of caspase3/7-mediated apoptosis corroborating the necrotic cell death results shown in [Figure 3](#fig3){ref-type="fig"}B and [Video S1](#mmc1){ref-type="supplementary-material"}. Taken together, these data indicate that intact TRPV4 protects host cells from *M. tuberculosis*-induced cell death.

Video S1. Study of Cell Death by Caspase3/7 AssayLive-cell imaging video of caspase3/7 assay in Mtb-infected WT and *Trpv4*^*−/−*^ macrophages. *M. tuberculosis*-DsRed (red) and caspase3/7 activity (green) was acquired in Cy3 and FITC channel, respectively. Related to Figure 3C.

Role of *Trpv4* in the Restriction of *M. tuberculosis* Growth in Infected Mice {#sec2.5}
-------------------------------------------------------------------------------

Next, we investigated the role of *Trpv4 in vivo* during *M. tuberculosis* infection. Upon aerosol infection with *M. tuberculosis*-H37Rv (100 colony-forming unit \[CFU\]), no significant differences in the survival rates of WT and *Trpv4*^*−/−*^ mice were observed during an observation period of up to 150 days p.i. (data not shown). Body weight analysis showed no difference between infected and non-infected WT mice up to 90 days p.i. In contrast, reduced weight gain was observed in *M. tuberculosis*-infected *Trpv4*^*−/−*^ mice of the same age starting at day 21 p.i. when compared with uninfected ones ([Figure 4](#fig4){ref-type="fig"}A). It should be noted that uninfected *Trpv4*^*−/−*^ mice, when compared with WT ones, continued to gain weight over a 7-week observation period.Figure 4Determination of *M. tuberculosis*-H37Rv Survival in WT and *Trpv4*^*−/−*^Mice(A) Body weights of *M. tuberculosis*-H37Rv-infected and uninfected WT and *Trpv4*^*−/−*^ mice were measured during the course of infection and presented as mean weight in g.(B) WT and *Trpv4*^*−/−*^ mice were exposed to *M. tuberculosis* aerosols (100 CFU), and bacterial burden in lungs was assessed at indicated time points by CFU assay. "n" indicates number of mice. Each point corresponds to one mouse. Statistical analysis was performed with two-way ANOVA Bonferroni post-tests. ∗∗p \< 0.01.(C) Acid fast staining was performed to determine the *M. tuberculosis* (pink and arrow marked) burden in infected WT and *Trpv4*^*−/−*^ mice lungs at day 29 p.i. Images were taken from three different fields (scale bar= 20 μm).(D) *M. tuberculosis*-infected lung sections from WT mice were prepared at indicated time points after infection, immune-stained with Trpv4 antibody (ACC034 Alomone lab 1:200), and then developed with oxidation of 3,3\'-diaminobenzidin (DAB) staining (brown) to check Trpv4 expression. Uninfected *Trpv4*^*−/−*^ and WT lung sections were used as negative and positive controls, respectively (scale bar of magnified image= 20 μm).(E--G) (E) Lung lesions (indicated by arrow) in *M. tuberculosis*-infected WT and *Trpv4*^*−/−*^ mice are depicted for the different time points p.i. H & E staining of (F) day 29 and (G) day 55 post *M. tuberculosis*-infected WT and *Trpv4*^*−/−*^ mice lung section indicates immune cell infiltration. Images were acquired with Olympus BX41 light microscope with 10X magnification.

At 29 days p.i., both, CFU and Ziel-Nielssen\'s staining showed higher *M. tuberculosis* counts in *Trpv4*^*−/−*^ lungs than in WT ones ([Figures 4](#fig4){ref-type="fig"}B and 4C). At day 55 and 90 p.i. both, WT and *Trpv4*^*−/−*^ mice were similarly able to control the mycobacteria. To our surprise, significantly lower *M. tuberculosis* counts were found in lungs from *Trpv4*^*−/−*^ mice at day 150 p.i. when compared with lungs from WT animals. In spleens of *Trpv4*^*−/−*^ mice, we also found less *M. tuberculosis* counts at day 150 p.i. when compared with WT ones, despite almost similar counts at earlier time points p.i. ([Figure S3](#mmc1){ref-type="supplementary-material"}A). No significant differences in mycobacterial counts between WT and *Trpv4*^*−/−*^ mice were seen in the livers during the entire course of infection ([Figure S3](#mmc1){ref-type="supplementary-material"}B). Immuno-histological analysis of WT lungs showed TRPV4-expressing cells at the periphery of granuloma, whereas cells present in the center showed reduced TRPV4 expression (arrow marked) ([Figure 4](#fig4){ref-type="fig"}D). Pulmonary inflammatory lesions (arrow marked) were larger in WT compared with *Trpv4*^*−/−*^ mice at days 55, 90, and 150 p.i. ([Figure 4](#fig4){ref-type="fig"}E). H&E staining revealed larger areas of inflammatory infiltrates at the site of infection in *M. tuberculosis*-infected WT mouse lungs at day 29 ([Figure 4](#fig4){ref-type="fig"}F) and day 55 ([Figure 4](#fig4){ref-type="fig"}G) p.i. when compared with *M. tuberculosis*-infected *Trpv4*^*−/−*^mouse lungs. These data indicate that TRPV4 is involved in the immune responses, which control *M. tuberculosis* burden in mice, however, with opposite functions, i.e., protective versus pathological, in the early versus late stage of infection.

*M. tuberculosis* utilizes host lipid droplets as nutrient source for growth in granulomas ([@bib4]). Using oil red O staining of lung tissue sections, we already noticed more lipid droplets in lungs from uninfected WT mice when compared with *Trpv4*^*−/−*^ones ([Figure S3](#mmc1){ref-type="supplementary-material"}D). More importantly, at day 55 p.i., *M. tuberculosis*-infected WT mice showed intense accumulation of lipid bodies in the lungs, which was more pronounced when compared with *Trpv4*^*−/−*^mice ([Figures 5](#fig5){ref-type="fig"}A and [S3](#mmc1){ref-type="supplementary-material"}C).Figure 5Analysis of Lipid Bodies, Cytokine, Chemokine, and Nitrite Production in *M. tuberculosis*-Infected WT and *Trpv4*^*−/−*^ Mice(A) Lipid staining of lung sections obtained from WT and *Trpv4*^*−/−*^ mice was performed using oil red O at day 55 post infection (nuclei, blue; lipid bodies, red). Lung lysates from *M. tuberculosis*-infected WT and *Trpv4*^*−/−*^ mice were prepared at different time points (Scale bar = 200 μm).(B--H) Protein estimation was performed to ensure use of equal protein concentration in analysis. The production of (B) IFN-γ, (C) IL-17A, (D) TNF-α, (E) IL-1β, (F) MCP-1, (G) MIP-2, and (H) IL-10 were determined using MSD assay kit.(I) Nitrite production was measured in lung lysates prepared from *M. tuberculosis*-infected WT and *Trpv4*^*−/−*^ mice at 15 day p.i. using nitrate reductase and Griess reagent. The NO~2~^-^ production was represented as the absorbance of Griess reagent at 543 nm. "n" corresponds to number of mice. Statistical analysis was performed with two-way ANOVA Bonferroni post-tests. Mean ± SEM, ∗p \< 0.05, ∗∗\<p \< 0.01, ∗∗∗p \< 0.001.

Reduced Pro-inflammatory Responses in *Trpv4*^*−/−*^ Mice upon *M. tuberculosis* Infection {#sec2.6}
------------------------------------------------------------------------------------------

Infiltration of immune cells to the site of infection is crucial for the restriction of *M. tuberculosis* growth *in vivo*. Analysis of a panel of cytokines and chemokines in lung lysates of *M. tuberculosis*-infected mice showed higher production of the pro-inflammatory cytokines, IFN-γ, IL-17A, TNF-α, and IL-1β in WT than in *Trpv4*^*−/−*^ mice. IFN-γ production was enhanced in both, WT and *Trpv4*^*−/−*^ compared with uninfected mice, although WT mice showed moderately higher IFN-γ production than *Trpv4*^*−/−*^ ones ([Figure 5](#fig5){ref-type="fig"}B). We also observed higher concentrations of IL-17A, TNF-α, and IL-1β in WT than in TRPV4^−/−^ lungs at day 29 p.i. ([Figures 5](#fig5){ref-type="fig"}C--5E). Upon infection, the production of keratinocyte chemoattractant (KC) was increased in WT when compared with *Trpv4*^*−/−*^ lungs, whereas IL-6 secretion was only moderately but not significantly enhanced ([Figures S4](#mmc1){ref-type="supplementary-material"}A and S4B). Similarly, we observed higher concentrations of the chemokines, monocyte chemoattractant protein-1 (MCP-1), and macrophage inflammatory protein 2 (MIP-2 or CXCL2) in lungs from WT when compared with those from *Trpv4*^*−/−*^ mice ([Figures 5](#fig5){ref-type="fig"}F and 5G). In contrast, the anti-inflammatory cytokine, IL-10, was significantly increased in *Trpv4*^*−/−*^ lung tissue samples taken at day 15 and, again, at day 55 p.i. when compared with WT lungs. Comparable IL-10 concentrations were observed at day 29 p.i. ([Figure 5](#fig5){ref-type="fig"}H).

Determination of NO~2~^-^ production at day 15 p.i. with *M. tuberculosis* showed enhanced NO~2~^-^ concentrations in the lungs from WT but not *Trpv4*^*−/−*^ mice. No differences in nitrite concentrations were observed in serum samples ([Figures 5](#fig5){ref-type="fig"}I and [S4](#mmc1){ref-type="supplementary-material"}C).

Differential TRPV4 Distribution in Granulomas from Patients with TB {#sec2.7}
-------------------------------------------------------------------

To investigate whether TRPV4 is also present in granulomas of human patients with TB, we analyzed TRPV4 expression in tissue section of lung granulomas obtained from three patients with TB, who had undergone lung tissue resection. We observed more TRPV4-positive cells at the periphery of the granuloma in all three patients, whereas cells in the center showed much weaker TRPV4 signals ([Figure 6](#fig6){ref-type="fig"}A). Dual staining with antibodies against the CD68 macrophage marker and TRPV4 in consecutive sections showed that TRPV4 expression did partially overlap with CD68-positive macrophages but was also associated with CD68-negative cells. CD68-positive cells present at the periphery of granulomas expressed more TRPV4, whereas those present at the center of the granuloma showed less TRPV4 ([Figures 6](#fig6){ref-type="fig"}B and 6C).Figure 6Analysis of TRPV4 Expression in Lung Granulomas of a Patient with TBLung tissue sections were obtained from patients with TB, who underwent anti-TB therapy and lung tissue resection as part of the treatment.(A) Immunohistochemistry was performed using an antibody to TRPV4, followed by a species-specific secondary antibody and DAB development (TRPV4, brown; nuclei, blue).(B and C) Human lung tissue sections of patients with TB were stained for TRPV4 and CD68 and developed by DAB staining showing expression of TRPV4 and CD68 in TB granuloma (TRPV4 and CD68, brown; nuclei, blue; Scale bar = 100 μm).

Neutrophils represent the predominant cell population infected with *M. tuberculosis* in pulmonary samples from patients with active TB and are thought to fail controlling the infection and rather drive exacerbation of inflammation ([@bib3], [@bib7]). Using immunofluorescence staining for neutrophil elastase (NE), we observed increasing numbers of NE-positive neutrophils in lungs from *M. tuberculosis-*infected WT mice between day 55 and 150 p.i., whereas only few NE signals were found in *Trpv4*^*−/−*^ lungs ([Figures 7](#fig7){ref-type="fig"}A and 7B). Notably, we also observed TRPV4-positive neutrophil aggregates in blood vessels in close proximity to the granulomatous tissue from patients with active TB ([Figure 7](#fig7){ref-type="fig"}C). In summary, TRPV4 in human TB lesions was primarily associated with macrophages and neutrophils, and in mice, recruitment of neutrophils was reduced in the absence of TRPV4 at later time points of *M. tuberculosis* infection, indicating a link between TRPV4 expression and neutrophil-associated inflammation.Figure 7Expression of Neutrophil Elastase in *M. tuberculosis*-Infected Mouse Lung(A--C) (A and B) WT and *Trpv4*^*−/−*^mice were infected with *M. tuberculosis* (100 CFU) via aerosol, and 4-μm cryosections of lung tissue samples were prepared after days 55 and 150 p.i. Tissue sections were stained by fluorescence immunohistochemistry assay for neutrophil elastase (green). Images were acquired from three different zones of infection (field) from each mouse; Scale bar=20 μm). Mean fluorescence intensity (MFI) of neutrophil elastase staining was quantified by using Fiji ImageJ software. (C) Human lung tissue sections of patients with TB were stained for TRPV4 showing positive signals in polymorphonuclear neutrophils in a blood vessel at the site of infection (Scale bar of R1, R2 = 20 μm).

Discussion {#sec3}
==========

In immune cells, different ion channels such as voltage-gated calcium channels, non-selective calcium channel, and transient receptor potential (TRP) ion channels are crucial for the regulation of calcium levels to facilitate cellular signaling pathways and effector functions ([@bib23]). Here, we report that virulent, but not attenuated *M. tuberculosis,* down-regulated *Trpv4* expression in murine macrophages, indicating that *M. tuberculosis* can interfere with TRPV4 function. Importantly, we revealed that *M. tuberculosis-*regulated *Trpv4* expression may critically be involved in modulating TB disease progression. In the absence of *Trpv4*, resting but even more prominently, IFN-γ activated *Trpv4*^−/−^macrophages failed to control growth of intracellular *M. tuberculosis*. This *in vitro* susceptibility phenotype corresponded to the failure of *Trpv4*^*−/−*^ mice in restricting pulmonary mycobacterial numbers in the early stage of infection during the growth phase of *M. tuberculosis*. In contrast, the lack of *Trpv4* was associated with better control of mycobacteria at the later chronic stage of infection. Thus, TRPV4 has a biphasic function associated with an early protective but later permissive phenotype. Association of functional TRPV4 with higher susceptibility to *M. tuberculosis* at later stages of infection in the murine TB model was paralleled by the presence of TRPV4-expressing macrophages and neutrophils in the periphery of granulomas from chronically infected WT mice and patients with active TB.

As a hallmark of *M. tuberculosis* virulence, the pathogen is able to inhibit phagosome acidification, a prerequisite for phagosome maturation and phago-lysosome fusion ([@bib28]). We found that, at 24 h p.i., WT but not ΔRD1 *M. tuberculosis* infection moderately reduced intracellular calcium levels in WT macrophages, indicating that *M. tuberculosis* virulence genes encoded by the RD1 region are important for TRPV4 down-regulation and hence, reduction of calcium ion concentration, which otherwise is a prerequisite for phago-lysosome fusion ([Figures S4](#mmc1){ref-type="supplementary-material"}D and S4E). Thereby, *M. tuberculosis* is able to maintain an immature phagosomal state as niche for intracellular growth, even in IFN-γ-activated macrophages ([@bib26]). This notion is supported by the retention of Rab-5 in *M. tuberculosis* phagosomes in TRPV4-deficient macrophages. This is not seen in mycobacterial phagosomes of WT macrophages, which efficiently delivered WT *M. tuberculosis* into phago-lysosomes. In fact, we also observed lower calcium uptake in resting *Trpv4*^*−/−*^ compared with WT macrophages when incubated with ionomycin Ca^2+^ ([Figure S4](#mmc1){ref-type="supplementary-material"}F). Increased cytosolic calcium levels enhance phagosome acidification. Accordingly, inhibition of calcium signaling by *M. tuberculosis* can interfere with phago-lysosome fusion, thereby promoting the pathogen\'s intracellular survival ([@bib15]). Beyond mycobacteria, hampered phagosome maturation in the absence of TRPV4 seems a general phenotype as acidification of phagosomes containing fixed *E. coli* cells was also delayed. Taken together, our results suggest that virulent *M. tuberculosis,* in addition to other virulence mechanisms, target *Trpv4,* thereby impairing phagosome acidification and maturation to secure intracellular survival and growth. To see whether the *in vitro* susceptibility phenotype of *Trpv4*^−/−^ macrophages is also relevant for bacterial infections other than mycobacterial ones, we infected WT versus *Trpv4*^*−/−*^ BMDM with *Salmonella typhimurium*. In contrast to mycobacteria, the salmonellae grew similarly in WT and *Trpv4*^*−/−*^ macrophages (data not shown), indicating that the observed phenotype is mycobacteria specific.

*M. tuberculosis* infection promotes apoptosis of human alveolar macrophages ([@bib12]). Staining for active caspase3/7 revealed that *Trpv4*^*−/−*^macrophages infected with *M. tuberculosis* succumbed to apoptotic cell death earlier than WT cells, which was likely due to higher intracellular mycobacterial burden 36 h p.i. Using live-cell imaging, we observed that apoptotic cells were engulfed by bystander macrophages leading to removal of more than 90% *Trpv4*^*-/-*^macrophages by 72 h p.i. These results indicate a relevance of *Trpv4* in *M. tuberculosis*-mediated host cell death.

Aerosol infection of *Trpv4*^*−/−*^mice and their WT littermates with *M. tuberculosis* revealed that the lack of *Trpv4* led to higher bacterial burden at day 29 p.i., but equal ones at days 55 and 90, and significantly lower ones at days 150 p.i. Reduced control of *M. tuberculosis* in mice lacking *Trpv4* in the early stage of infection is likely due to the failure of TRP4-deficient macrophages to promote phagosome maturation and RNS production. Moreover, inflammatory responses were reduced in *Trpv4*^*−/−*^ lungs when compared with WT littermates including smaller inflammatory infiltrates and granuloma-like structures at the site of infection. This could be due to lower concentrations of MCP-1 and MIP-2, which are involved in the recruitment of immune cells to the infection sites, in *M. tuberculosis*-infected *Trpv4*^*−/−*^ versus WT lungs ([Figures 4](#fig4){ref-type="fig"}F and 4G), which corroborates previous observations ([@bib29]). IFN-γ and IL-17 production was increased in lungs of WT, but not of *Trpv4*^*−/−*^, mice at day 29 post *M. tuberculosis* infection and associated with reduced TNF-α production otherwise important for optimal macrophage activation. These data suggest that *Trpv4*^*−/−*^ mice failed to develop sufficient innate immune responses to combat *M. tuberculosis*. In contrast, enlarged lung lesions and higher concentrations of pro-inflammatory cytokines and effectors produced in WT when compared with *Trpv4*^*−/−*^ mice were likely instrumental in controlling *M. tuberculosis* growth in the presence of *Trpv4*. Increased secretion of the anti-inflammatory cytokine, IL-10, in *Trpv4*^*−/−*^ versus WT mice infected with *M. tuberculosis* is likely responsible for this reduced Th1 response observed. Enhanced influx of neutrophils in WT compared with TRPV4^−/−^ mice at the later stage of infection is likely contributing to enhanced inflammation in the presence of TRPV4. Inhibited TRPV4 has been shown to limit neutrophil functions including chemotaxis ([@bib30]). Excessive secretion of neutrophil elastase by activated neutrophils is involved in the control of *M. tuberculosis,* but at the same time, can also cause tissue damage and pathology. Thus, TRPV4 has a protective role in *M. tuberculosis* infection during the early innate immune response phase before T cell immunity kicks in, but a detrimental one later in infection when exacerbated inflammatory responses including neutrophil influx maintain mycobacterial growth.

The appearance of lipid-storing macrophages as characterized by lipid droplets (LD) is a histopathological hallmark of the chronically *M. tuberculosis*-infected murine lung later in infection. LD formation in *M. tuberculosis*-infected macrophages has been suggested to be a programmed host response coordinated by IFN-γ ([@bib14]). However, *M. tuberculosis* can utilize fatty acids stored in LDs as carbon source for intracellular growth. Thus, our observation that pulmonary lesions in *Trpv4*^*−/−*^ mice contained less LDs than those in WT mice may also account for lower mycobacterial loads in *Trpv4*^*−/−*^ compared with WT lungs at late stage of infection, i.e., day 150. This phenotype is likely caused by a reduced IFN-γ and neutrophil-driven inflammatory environment promoted by enhanced IL-10 production in the absence of *Trpv4*. Apart from providing a food source for mycobacteria, LDs are also involved in the production of pro-inflammatory eicosanoids such as prostaglandin E~2~, which promote neutrophil influx into the infected tissue. As such, lower numbers of LDs in lungs of *M. tuberculosis-*infected *Trpv4*^*−/−*^ mice might be responsible for reduced inflammatory responses and neutrophil aggregations when compared with WT lungs ([@bib11], [@bib22]).

The relevance of TRPV4 in *M. tuberculosis* infection identified by our experimental studies in mice prompted us to analyze its presence in human TB lesions. Immuno-histopathological analyses of lung granuloma sections from three patients with TB showed TRPV4-expressing macrophages at the periphery of the necrotic granuloma, whereas those in the centers showed less TRPV4 expression. Exposure of macrophages to *M. tuberculosis* and its metabolites, which happens more likely in the center of TB granulomas, as well as subsequent necrotic cell death may account for the reduced TRPV4 expression observed. It should, however, be noted that the patients with TB, from which the tissue samples were derived, had a history of long-term anti-TB treatment. Nevertheless, surgery was needed to overcome prolonged culture positivity and imminent treatment failure. Consequently, bacterial loads through acid-fast staining could not be visualized despite the strong and obvious granulomatous lesions present. Notably, TRPV4 was also observed in neutrophils in the granuloma-adjacent blood vessels. This finding supports previous reports that TRPV4 deficiency impairs neutrophil response to pro-inflammatory stimuli, production of reactive oxygen species, adhesion, and chemotaxis ([@bib30]).

Taken together, we report a novel bifunctional role of the TRPV4 ion channel in host responses to *M. tuberculosis* infection in mice, in which TRPV4 is protective during the early innate but exacerbating and proinflammatory during the late chronic stage of infection. To this end, the presence of TRPV4-expressing myeloid cells in lung granulomas indicates TRPV4 as a potential target to be explored for host-directed therapy to control TB disease progression and support antibiotic treatment.

Limitations of the Study {#sec3.1}
------------------------

In this study, although we have observed down-regulation of TRPV4 by pathogenic *M. tuberculosis* H37Rv in macrophages, we believe that TRPV4 expression can also be regulated by other intracellular factors during *in vitro* culture in the absence of an infectious stimulus ([Figure 1](#fig1){ref-type="fig"}B uninfected condition). In our follow-up studies, we will compare TRPV4 expression in different innate and acquired immune cell populations from un-infected versus infected mice to delineated regulatory mechanisms, as well as the kinetics of immune cell frequencies during the infectious process to identify responses responsible for higher and lower susceptibility of *Trpv4*^*−/−*^ mice early versus later in infection. Future availability of specific TRPV4 inhibitors employable *in vivo*, will allow to explore the host-directed therapy approach targeting TRPV4 in late stage of infection using a susceptible mouse model of TB. Ultimately, the cellular and molecular functions of TRPV4 and its putative interaction partners during macrophage responses to *M. tuberculosis* need to be approached using cell biology and biochemistry approaches. Our observation of a decreased neutrophil influx in lungs of *M. tuberculosis*-infected *Trpv4*^*−/−*^ mice late in infection also requires further investigations to understand the underlaying molecular and immunological mechanisms of how TRPV4 is involved here and how this knowledge can be explored to improve treatment of tuberculosis.

Resource Availability {#sec3.2}
---------------------

### Lead Contact {#sec3.2.1}

Further information and requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Prof. Dr. Ulrich E. Schaible (<uschaible@fz-borstel.de>).

### Materials Availability {#sec3.2.2}

This study did not generate new unique reagents.

### Data and Code Availability {#sec3.2.3}

This study did not generate datasets/code.

Methods {#sec4}
=======

All methods can be found in the accompanying [Transparent Methods supplemental file](#mmc1){ref-type="supplementary-material"}.
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